Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Rubboli

Showing results (21-30 of 201) with videos related to

Pageof 21
Sort By:
Cardiology|January 6, 2026
Subclinical Atherosclerotic Coronary Artery Disease: Considerations on a New Modifier of Cardiovascular RiskAndrea Rubboli, Dan Atar
Giornale Italiano Di Cardiologia (2006)|September 30, 2015
[The ENGAGE AF-TIMI 48 study]Andrea Rubboli, Paolo Colonna
Current Vascular Pharmacology|January 19, 2018
What is the Role for Glycoprotein IIb/IIIa Inhibitor Use in the Catheterization Laboratory in the Current Era?Andrea Rubboli, Giuseppe Patti
European Journal of Internal Medicine|June 6, 2021
The debated issue of direct oral anticoagulants correct dosing: When even the reviewer is confusedAndrea Rubboli, Dan Atar
Giornale Italiano Di Cardiologia (2006)|June 20, 2020
[Arithmetic of non-vitamin K antagonist oral anticoagulants in non-valvular atrial fibrillation]Andrea Rubboli, Sabine Vecchio
Giornale Italiano Di Cardiologia (2006)|August 2, 2013
[The WOEST study]Andrea Rubboli, Ugo Limbruno
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 13, 2021
Modulating the Intensity of Oral Anticoagulation Therapy with Direct Oral Anticoagulants: Feasible or Not?Andrea Rubboli, Dan Atar
Giornale Italiano Di Cardiologia (2006)|October 27, 2025
[Incidental finding of non-obstructive coronary artery disease in an asymptomatic subject: what to do?]Andrea Rubboli, Nuccia Morici
European Heart Journal|January 16, 2025
EuroThrombosis and EuroVessels (ETEV) 2024Andrea Rubboli, Oliver Schlager
Cardiovascular Drugs and Therapy|May 12, 2019
After the AUGUSTUS Trial, Should Apixaban Be the Only Direct Oral Anticoagulant to Be Used in Triple Therapy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention?Andrea Rubboli, Matteo Lisi
Pageof 21

Showing results (21-30 of 201) with videos related to

Sort By:
Pageof 21
Cardiology|January 6, 2026
Subclinical Atherosclerotic Coronary Artery Disease: Considerations on a New Modifier of Cardiovascular RiskAndrea Rubboli, Dan Atar
Giornale Italiano Di Cardiologia (2006)|September 30, 2015
[The ENGAGE AF-TIMI 48 study]Andrea Rubboli, Paolo Colonna
Current Vascular Pharmacology|January 19, 2018
What is the Role for Glycoprotein IIb/IIIa Inhibitor Use in the Catheterization Laboratory in the Current Era?Andrea Rubboli, Giuseppe Patti
European Journal of Internal Medicine|June 6, 2021
The debated issue of direct oral anticoagulants correct dosing: When even the reviewer is confusedAndrea Rubboli, Dan Atar
Giornale Italiano Di Cardiologia (2006)|June 20, 2020
[Arithmetic of non-vitamin K antagonist oral anticoagulants in non-valvular atrial fibrillation]Andrea Rubboli, Sabine Vecchio
Giornale Italiano Di Cardiologia (2006)|August 2, 2013
[The WOEST study]Andrea Rubboli, Ugo Limbruno
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 13, 2021
Modulating the Intensity of Oral Anticoagulation Therapy with Direct Oral Anticoagulants: Feasible or Not?Andrea Rubboli, Dan Atar
Giornale Italiano Di Cardiologia (2006)|October 27, 2025
[Incidental finding of non-obstructive coronary artery disease in an asymptomatic subject: what to do?]Andrea Rubboli, Nuccia Morici
European Heart Journal|January 16, 2025
EuroThrombosis and EuroVessels (ETEV) 2024Andrea Rubboli, Oliver Schlager
Cardiovascular Drugs and Therapy|May 12, 2019
After the AUGUSTUS Trial, Should Apixaban Be the Only Direct Oral Anticoagulant to Be Used in Triple Therapy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention?Andrea Rubboli, Matteo Lisi
Pageof 21